Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy-Reference-Cited by-同舟云学术

Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy

Published:2015-10-26 Issue:7577 Volume:527 Page:249-253
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Peng Dongjun,Kryczek Ilona,Nagarsheth Nisha,Zhao Lili,Wei Shuang,Wang Weimin,Sun Yuqing,Zhao Ende,Vatan Linda,Szeliga Wojciech,Kotarski Jan,Tarkowski Rafał,Dou Yali,Cho Kathleen,Hensley-Alford Sharon,Munkarah Adnan,Liu Rebecca,Zou Weiping

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature15520.pdf

Reference35 articles.

1. Timp, W. & Feinberg, A. P. Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nature Rev. Cancer 13, 497–510 (2013)

2. Curiel, T. J. et al. Blockade of B7–H1 improves myeloid dendritic cell-mediated antitumor immunity. Nature Med. 9, 562–567 (2003)

3. Zou, W. & Chen, L. Inhibitory B7-family molecules in the tumour microenvironment. Nature Rev. Immunol. 8, 467–477 (2008)

4. Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy. Nature Rev. Cancer 12, 252–264 (2012)

5. Rosenberg, S. A., Restifo, N. P., Yang, J. C., Morgan, R. A. & Dudley, M. E. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nature Rev. Cancer 8, 299–308 (2008)

Cited by 924 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unleashing precision: A review of targeted approaches in pleural mesothelioma;Critical Reviews in Oncology/Hematology;2024-11

2. Regulation of protein phosphorylation by PTPN2 and its small-molecule inhibitors/degraders as a potential disease treatment strategy;European Journal of Medicinal Chemistry;2024-11

3. FOXF1 inhibits invasion and metastasis of lung adenocarcinoma cells and enhances anti-tumor immunity via MFAP4/FAK signal axis;Scientific Reports;2024-09-13

4. Epigenetics and immunotherapy in colorectal cancer: progress and promise;Clinical Epigenetics;2024-09-10

5. Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy;Biomarker Research;2024-09-04